3 Einträge gefunden

1. Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines

   1. Ascher, Benjamin
   2. Rzany, Berthold
   3. Kestemont, Philippe
   4. Hilton, Said
   5. Heckmann, Marc
   6. Bodokh, Isaac
   7. Noah, Ernst Magnus

   2020 - Forschungsinformationssystem der UHH - frei zugänglich
2. Significantly increased patient satisfaction following liquid formulation abobotulinumtoxina treatment in glabellar lines:FACE-Q outcomes from a phase 3 clinical trial

   1. Ascher, Benjamin
   2. Rzany, Berthold
   3. Kestemont, Philippe
   4. Hilton, Said
   5. Heckmann, Marc
   6. Bodokh, Isaac
   7. Noah, Ernst Magnus

   2020 - Forschungsinformationssystem der UHH - frei zugänglich
3. Response to "facial Line Outcomes (FLO-11) and Facial Line Satisfaction Questionnaire (FLSQ) Meet FDA PRO Guidance"

   1. Ascher, Benjamin
   2. Rzany, Berthold
   3. Kestemont, Philippe
   4. Hilton, Said
   5. Heckmann, Marc
   6. Bodokh, Isaac
   7. Noah, Ernst Magnus

   2020 - Forschungsinformationssystem der UHH - frei zugänglich